Mutant fragments of OspA and methods and uses relating thereto
AssigneeValneva Austria GmbH
InventorsUrban Lundberg, Wolfgang Schüler
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods for the prevention and treatment of Borrelia infection. Particularly, the present invention relates to a polypeptide comprising a hybrid C-terminal fragment of an outer surface protein A (OspA), a nucleic acid coding the same, an antibody specifically binding the same, a pharmaceutical composition (particularly for use as a medicament or in a method of treating or preventing a Borrelia infection) comprising the polypeptide and/or the nucleic acid and/or the antibody, a method of treating or preventing a Borrelia infection and a method of immunizing a subject.
Claims23
A nucleic acid encoding a polypeptide comprising a first disulfide bond-stabilized C-terminal fragment of an outer surface protein A (OspA),
- wherein said first disulfide bond-stabilized C-terminal fragment is a hybrid C-terminal OspA fragment consisting of, from the N- to C-terminal direction, a fusion of a first and a second OspA portion from two different Borrelia strains, wherein said polypeptide induces an immune response protective against a Borrelia infection, and wherein:
- i) said first OspA portion consists of amino acids 125-176 or amino acids 126-175 of OspA from a Borrelia strain that is not the corresponding fragment of B. garinii, strain PBr OspA with SEQ ID NO:
- 8, wherein the numbering of amino acids is according to the numbering of corresponding amino acids of the full-length OspA of B. burgdoferi s.s., strain B31 with SEQ ID NO:
- 5;
- and
- ii) said second OspA portion consists of amino acids 176-274 or amino acids 177-274 of OspA from B. garinii, strain PBr (SEQ ID NO:
- 8), wherein the second OspA portion differs from the corresponding wild-type sequence of SEQ ID NO:
- 8 at least by
- a) substitution of the wild-type amino acid at position 183+/−3 of SEQ ID NO:
- 8 by a cysteine, and
- b) substitution of the wild-type amino acid at position 270+/−3 of SEQ ID NO:
- 8 by a cysteine,
- wherein a disulfide bond between the introduced cysteines is present.
A nucleic acid encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:
- 27.
A nucleic acid comprising the nucleic acid sequence of SEQ ID NO:
- 26.
Dependencies are inferred from the claim text.